HONG KONG – Expansion among Chinese biotech companies China Biologic Products Inc. (CBPO) and Wuxi Pharmatech (Cayman) Inc. that recently announced full-year 2014 results has ranged from fast to too fast – with the former seeing a more than doubling of its share price and the latter watching its shares tumble over the past year.